Skip to main content
MBX
NASDAQ Life Sciences

Major Investor OrbiMed Reduces Stake in MBX Biosciences Below 10%

Analysis by Wiseek AI
Sentiment info
Negative
Importance info
7
Price
$35.5
Mkt Cap
$1.572B
52W Low
$4.807
52W High
$44.89
Market data snapshot near publication time

Summary

OrbiMed Advisors and its affiliated funds reported a reduction in their beneficial ownership of MBX Biosciences to 7.7%, primarily due to dilution from a recent ATM offering and active share sales totaling approximately $12.74 million.


Key Events

  • OrbiMed's Stake Reduced

    OrbiMed Advisors and its affiliated funds now beneficially own 7.7% of MBX Biosciences' common stock, down from an implied previous stake above 8.7%.

  • Significant Share Sales

    OrbiMed funds sold approximately 364,000 shares between December 26, 2025, and January 16, 2026, for an estimated total value of $12.74 million.

  • Dilution from ATM Offering

    The reduction in percentage ownership was partly driven by the increase in outstanding shares from MBX Biosciences' at-the-market offering, which was completed on February 5, 2026.

  • Retains Registration Rights

    OrbiMed continues to hold demand, Form S-3, and piggyback registration rights, allowing them to request the company to register their shares for sale in the future.


Analysis

This Schedule 13D/A filing indicates that OrbiMed, a significant institutional investor, has reduced its beneficial ownership in MBX Biosciences to 7.7%. The decrease in percentage ownership is attributed to the company's recent at-the-market (ATM) offering, which increased the total number of outstanding shares, as well as active sales by OrbiMed's funds between late December 2025 and mid-January 2026. The sales, totaling approximately $12.74 million, represent a notable disposition by a major shareholder. While the ATM offering was previously disclosed, the specific details of OrbiMed's sales and the resulting ownership percentage are new and signal a reduction in conviction or a portfolio rebalancing by a key investor.

At the time of this filing, MBX was trading at $35.50 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.6B. The 52-week trading range was $4.81 to $44.89. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

MBX - Latest Insights

MBX
Jun 12, 2026, 7:05 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $35.00
Real-time Price: $34.80 info
Change: -$0.200 (-0.57%) info
Market Cap: $1.69B info
MBX
Jun 12, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $35.00
Real-time Price: $34.80 info
Change: -$0.200 (-0.57%) info
Market Cap: $1.69B info
MBX
May 11, 2026, 7:04 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $41.21
Real-time Price: $34.80 info
Change: -$6.41 (-16%) info
Market Cap: $1.69B info
MBX
May 08, 2026, 4:05 PM EDT
Filing Type: DEFA14A
Importance Score:
7
Price at Filing: $40.97
Real-time Price: $34.80 info
Change: -$6.17 (-15%) info
Market Cap: $1.69B info
MBX
May 07, 2026, 9:03 AM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $29.50
Real-time Price: $34.80 info
Change: +$5.30 (+18%) info
Market Cap: $1.69B info
MBX
Apr 22, 2026, 8:04 AM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $33.24
Real-time Price: $34.80 info
Change: +$1.56 (+5%) info
Market Cap: $1.69B info
MBX
Mar 16, 2026, 8:02 AM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $28.30
Real-time Price: $34.80 info
Change: +$6.50 (+23%) info
Market Cap: $1.69B info
MBX
Mar 12, 2026, 4:07 PM EDT
Filing Type: S-3ASR
Importance Score:
8
Price at Filing: $27.95
Real-time Price: $34.80 info
Change: +$6.85 (+25%) info
Market Cap: $1.69B info
MBX
Mar 12, 2026, 8:05 AM EDT
Filing Type: 10-K
Importance Score:
8
Price at Filing: $28.91
Real-time Price: $34.80 info
Change: +$5.89 (+20%) info
Market Cap: $1.69B info
MBX
Mar 12, 2026, 8:02 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $28.91
Real-time Price: $34.80 info
Change: +$5.89 (+20%) info
Market Cap: $1.69B info